{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:48:37Z","timestamp":1778575717849,"version":"3.51.4"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18059186"],"award-info":[{"award-number":["18059186"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0239100","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T17:29:46Z","timestamp":1600104586000},"page":"e0239100","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8082-2036","authenticated-orcid":true,"given":"Yusuke","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yodo","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Yaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Inuzuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neiko","family":"Ozasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kitai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihito","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"key":"pone.0239100.ref001","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","author":"CONSENSUS Trial Study Group","year":"1987","journal-title":"N Engl J Med"},{"key":"pone.0239100.ref002","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"SOLVD Investigators","year":"1991","journal-title":"N Engl J Med"},{"key":"pone.0239100.ref003","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"SOLVD Investigators","year":"1992","journal-title":"N Engl J Med"},{"key":"pone.0239100.ref004","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Valsartan Heart Failure Trial Investigators","year":"2001","journal-title":"N Engl J Med"},{"key":"pone.0239100.ref005","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"CB Granger","year":"2003","journal-title":"Lancet"},{"key":"pone.0239100.ref006","first-page":"473","article-title":"Understanding Heart Failure With Mid-Range Ejection Fraction","volume":"4","author":"CSP Lam","year":"2016","journal-title":"J Am Coll Cardiol HF"},{"key":"pone.0239100.ref007","first-page":"464","article-title":"Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction","volume":"4","author":"JR Kapoor","year":"2016","journal-title":"J Am Coll Cardiol HF"},{"key":"pone.0239100.ref008","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1253\/circj.CJ-17-1386","article-title":"Demographics, Management, and In-Hospital Outcome of Hospitalized Acute Heart Failure Syndrome Patients in Contemporary Real Clinical Practice in Japan- Observations From the Prospective, Multicenter Kyoto Congestive Heart Failure (KCHF) Registry","volume":"82","author":"H Yaku","year":"2018","journal-title":"Circ J"},{"key":"pone.0239100.ref009","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"S Yusuf","year":"2003","journal-title":"Lancet"},{"key":"pone.0239100.ref010","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"JGF Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"pone.0239100.ref011","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"BM Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"pone.0239100.ref012","first-page":"808","article-title":"Refining Classification of Heart Failure Based on Ejection Fraction","volume":"5","author":"GC Fonarow","year":"2017","journal-title":"J Am Coll Cardiol HF"},{"key":"pone.0239100.ref013","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"P Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"pone.0239100.ref014","first-page":"e147","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"CW Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"pone.0239100.ref015","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/ehv464","article-title":"Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction","volume":"37","author":"SD Solomon","year":"2016","journal-title":"Eur Heart J"},{"key":"pone.0239100.ref016","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ejhf.1149","article-title":"Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum","volume":"20","author":"LH Lund","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"pone.0239100.ref017","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.119.044586","article-title":"Sacubitril\/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure","volume":"141","author":"SD Solomon","year":"2020","journal-title":"Circulation"},{"key":"pone.0239100.ref018","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/ejhf.159","article-title":"The middle child in heart failure: heart failure with mid-range ejection fraction (40\u201350%)","volume":"16","author":"CSP Lam","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"pone.0239100.ref019","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/ejhf.1058","article-title":"What have we learned about heart failure with mid-range ejection fraction one year after its introduction?","volume":"19","author":"JF Nauta","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"pone.0239100.ref020","unstructured":"Ministry of Education, Culture, Sports, Science and Technology, Ministry of Health, Labour and Welfare. Ethical guidelines for epidemiologic research. [Internet]. Available: http:\/\/www.lifescience.mext.go.jp\/les\/pdf\/n796_01.pdf"},{"key":"pone.0239100.ref021","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ehf2.12138","article-title":"Kyoto Congestive Heart Failure (KCHF) study: rationale and design","volume":"4","author":"E Yamamoto","year":"2017","journal-title":"ESC Heart Fail"},{"key":"pone.0239100.ref022","doi-asserted-by":"crossref","first-page":"e195892","DOI":"10.1001\/jamanetworkopen.2019.5892","article-title":"Association of Mineralocorticoid Receptor Antagonist Use With All-Cause Mortality and Hospital Readmission in Older Adults With Acute Decompensated Heart Failure","volume":"2","author":"H Yaku","year":"2019","journal-title":"JAMA Netw Open"},{"key":"pone.0239100.ref023","doi-asserted-by":"crossref","first-page":"e032674","DOI":"10.1136\/bmjopen-2019-032674","article-title":"Risk factors and clinical outcomes of functional decline during hospitalisation in very old patients with acute decompensated heart failure: an observational study","volume":"10","author":"H Yaku","year":"2020","journal-title":"BMJ Open"},{"key":"pone.0239100.ref024","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jcmg.2015.02.014","article-title":"Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function: The EchoNoRMAL Study","volume":"8","author":"Echocardiographic Normal Ranges Meta-Analysis of the Left Heart Collaboration","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"pone.0239100.ref025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"RM Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"pone.0239100.ref026","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/01.CIR.0000020014.14176.6D","article-title":"Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction","volume":"106","author":"Z Yang","year":"2002","journal-title":"Circulation"},{"key":"pone.0239100.ref027","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijcard.2019.08.040","article-title":"Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction","volume":"296","author":"G Vergaro","year":"2019","journal-title":"Int J Cardiol"},{"key":"pone.0239100.ref028","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCHEARTFAILURE.107.743146","article-title":"Death in heart failure: a community perspective","volume":"1","author":"DM Henkel","year":"2008","journal-title":"Circ Heart Fail"},{"key":"pone.0239100.ref029","doi-asserted-by":"crossref","first-page":"e013441","DOI":"10.1161\/JAHA.119.013441","article-title":"Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction","volume":"8","author":"G Vergaro","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"pone.0239100.ref030","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCHEARTFAILURE.111.966366","article-title":"Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction","volume":"5","author":"SM Dunlay","year":"2012","journal-title":"Circ Heart Fail"},{"key":"pone.0239100.ref031","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/ejhf.807","article-title":"Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study","volume":"19","author":"K Tsuji","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"pone.0239100.ref032","first-page":"763","article-title":"Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions","volume":"5","author":"JJ Hsu","year":"2017","journal-title":"J Am Coll Cardiol HF"},{"key":"pone.0239100.ref033","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1161\/CIRCULATIONAHA.117.027324","article-title":"Fussing Over the Middle Child: Heart Failure With Mid-Range Ejection Fraction","volume":"135","author":"CSP Lam","year":"2017","journal-title":"Circulation"},{"key":"pone.0239100.ref034","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0002-8703(03)00248-5","article-title":"Reliability of reporting left ventricular systolic function by echocardiography: A systematic review of 3 methods","volume":"146","author":"JH McGowan","year":"2003","journal-title":"Am Heart J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0239100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T08:56:18Z","timestamp":1696668978000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0239100"}},"subtitle":[],"editor":[{"given":"Vincenzo","family":"Lionetti","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0239100","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,14]]}}}